Sunday, April 30, 2017 1:45:48 PM
Dear %%%%%%%,
Thank you for your interest in BLDV.
The news that has been put out clearly states that we are in the process of raising money for the buildout on AMS, the construction costs money, and is the final step. The first 6 steps required intense vetting on personnal, capabilty and bsuiness plans along with significant vetting of proposed partners and procedures of fund raising.
AMS was caught in the middle in the way the licensing process was being implemmented, the good news is that the current enviroment in Canada has opened all the doors again.
The company raises money in a number of different ways and seeking to do so without significant dilution for the shareholders.
The late filing request was due to a memeber of out staff being scheduled for surgery and does not represent any change in our accounting pratices.
Again I thank you for your interest.
Regards,
Josh
Joshua Brainin Alper
CEO - Blue Diamond Ventures Inc.
otc Pinksheets: BLDV
Direct Line 312-296-8910
535 North Michigan Avenue - Suite 3001
Chicago Illinois 60611 - USA
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM